Gastrointestinal morbidity as primary outcome measure in studies comparing crystalloid and colloid within a goal-directed therapy.

Hunsicker, OScott, MJMiller, TEBaldini, GFeldheiser, A2018-07-242018-07-242015-010007-09121471-6771https://hdl.handle.net/10161/17261HumansColloidsIsotonic SolutionsFluid TherapyColorectal SurgeryFemaleMaleHydroxyethyl Starch DerivativesGastrointestinal morbidity as primary outcome measure in studies comparing crystalloid and colloid within a goal-directed therapy.Journal article2018-07-24